Rituximab in Lymphoma: After a Decade, We Continue to Learn
James Armitage: Rituximab in Lymphoma: After a Decade, We Continue to Learn
20100001
2010 Jan 1
Top Stories of 2009
Rituximab in Lymphoma: After a Decade, We Continue to Learn
Top Stories of 2009. 2010 Jan 1
Dr. Armitage is Joe Shapiro Professor of Medicine and Professor and Chair of Oncology, University of Nebraska Medical Center. View profile. 1. In your view, which development in the area of hematologic malignancies that has occurred in 2009 could have the most significant impact on oncology?The area of hematologic malignancies in which I have special interest is the care of people with lymphoma. Although there has not been any single observation that will completely change the way we approach these...
Editors' Choice
Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)
Meet Our Experts
Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.
